Published in Eur J Pharmacol on July 03, 1990
Bradykinin and oedema formation in heated paws of rats. Br J Pharmacol Chemother (1967) 2.11
Behavioural depressant and antinociceptive properties of substance P in the mouse: possible implication of brain monoamines. Eur J Pharmacol (1978) 1.40
Enzyme-potentiated hyposensitisation. I. The effect of pre-treatment with -glucuronidase, hyaluronidase, and antigen on anaphylactic sensitivity of guinea-pigs, rats and mice. Int Arch Allergy Appl Immunol (1972) 1.22
The effect of bradykinin and anti-inflammatory agents on isolated arteries. J Pharm Pharmacol (1966) 1.20
The uptake of ( 14 C) -aminobutyric acid by the isolated retina of the rat. Vision Res (1972) 1.19
Inhibition of anaphylactic shock in the rat by antihistamines and ascorbic acid. Br J Pharmacol Chemother (1966) 1.11
GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum. Eur J Pharmacol (1978) 1.06
Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects. Int Arch Allergy Appl Immunol (1970) 1.03
Effects of prostaglandins and a prostaglandin antagonist on intraocular pressure and protein in the monkey eye. Can J Ophthalmol (1971) 0.98
Further studies on the effect of prostaglandin on intraocular pressure in the rabbit. Exp Eye Res (1971) 0.92
Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors. Neuropharmacology (1986) 0.90
Effects of prostaglandin on blood flow in the rabbit eye. Exp Eye Res (1971) 0.89
The efflux of radioactive GABA from rat retina in vitro. Vision Res (1972) 0.89
Effect of inhibitors of -aminobutyrate aminotransferase on the accumulation of 3H- -aminobutyric acid by the retina. Br J Pharmacol (1973) 0.88
Evidence for the participation of nigrotectal gamma-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat. Neuroscience (1982) 0.88
Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol Biochem Behav (1993) 0.83
Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice. Neuropharmacology (1987) 0.82
Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease. Neurosci Biobehav Rev (1997) 0.82
Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylase. Amino Acids (1998) 0.82
Differential behavioural interactions between the dopamine D-1 antagonist SCH 23390 and the dopamine D-2 antagonists metoclopramide and sulpiride in nonhabituated mice. Pharmacol Biochem Behav (1990) 0.82
Studies in pollen allergy. I. A method for estimating histamine release from sensitised leucocytes in the presence of serum. Int Arch Allergy Appl Immunol (1970) 0.81
Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. Eur J Pharmacol (1981) 0.81
Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra. Neurosci Biobehav Rev (1997) 0.80
Seizure promotion by D1 agonists does not correlate with other dopaminergic properties. J Neural Transm Park Dis Dement Sect (1993) 0.80
Evidence for the compartmentation of glutamate metabolism in isolated rat retina. J Neurochem (1974) 0.80
Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies. Exp Brain Res (1980) 0.80
The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse. Pharmacol Biochem Behav (1994) 0.80
Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Eur J Pharmacol (1995) 0.80
Motor depression: a new role for D1 receptors? Neuroscience (1990) 0.80
Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices. J Neurochem (1975) 0.79
Evidence for a GABAergic nigrothalamic pathway in the rat. II. Electrophysiological studies. Exp Brain Res (1980) 0.79
SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors. Eur J Pharmacol (1985) 0.79
Effect of dark adaptation on the GABA system in retina. Brain Res (1973) 0.79
Behavioural and biochemical effects of substance P injected into the substantia nigra of the rat. J Pharm Pharmacol (1977) 0.79
Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors. Neuroscience (1993) 0.78
Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience (1987) 0.78
Nigral-derived muscimol circling--ipsiversive, contraversive or controversial? Nature (1981) 0.78
Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. J Pharm Pharmacol (1980) 0.78
Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Neuroscience (1987) 0.78
Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent. Neuroscience (2000) 0.78
GABA-mediated potentiation of amine release from nigrostriatal dopamine neurones in vitro. Eur J Pharmacol (1979) 0.78
Uptake of taurine by retina in different species. Brain Res (1978) 0.78
Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. J Neural Transm Park Dis Dement Sect (1992) 0.77
Role of the ventromedial nucleus of the thalamus in motor behaviour--I. Effects of focal injections of drugs. Neuroscience (1983) 0.77
Haemorrhagic, traumatic and tourniquet shock in the rat. J Pharm Pharmacol (1967) 0.77
Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390. Pharmacol Biochem Behav (1986) 0.77
Regional changes in brain dopamine utilization during status epilepticus in the rat induced by systemic pilocarpine and intrahippocampal carbachol. Neuropharmacology (1996) 0.77
Is glycine an inhibitory synaptic transmitter in the substantia nigra? Eur J Pharmacol (1979) 0.77
The uptake, metabolism and release of 14C-taurine by rat retina in vitro. Vision Res (1972) 0.77
Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. Brain Res (1997) 0.77
Is the animal's defence against injury and allergic phenomena linked with resistance to the anaphylactoid reaction? Int Arch Allergy Appl Immunol (1967) 0.77
Muscarinic action of acetylcholine in the rat ventromedial thalamic nucleus. Exp Brain Res (1984) 0.77
The effects of various amino acids, dopamine and some convulsants on the electroretinogram of the rabbit. Exp Eye Res (1975) 0.77
Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology (1990) 0.77
Implantation of dihydrotestosterone propionate into the lateral septum or medial amygdala facilitates copulation in castrated male rats given estradiol systemically. Horm Behav (1982) 0.77
Prospective neurotransmitters in vertebrate retina. Essays Neurochem Neuropharmacol (1977) 0.77
Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors. Pharmacol Biochem Behav (1989) 0.77
Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience (1997) 0.77
Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Neuroscience (1987) 0.77
Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain. Brain Res (2000) 0.77
D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmacol Biochem Behav (1991) 0.77
Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine. J Neural Transm Park Dis Dement Sect (1993) 0.76
Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid. Eur J Pharmacol (1999) 0.76
Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse. Eur J Pharmacol (1995) 0.76
Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits? Neuroscience (1991) 0.76
Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis. J Neural Transm Park Dis Dement Sect (1993) 0.76
Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatum. J Neurochem (1992) 0.76
Brain dopamine activity following intranigral or intrathalamic drug injections in the rat. Brain Res Bull (1985) 0.76
Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Synapse (1999) 0.76
Effects of substance P injected into the substantia nigra. Br J Pharmacol (1979) 0.76
Role of the ventromedial nucleus of the thalamus in motor behaviour--II. Effects of lesions. Neuroscience (1983) 0.76
NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. Eur J Pharmacol (1996) 0.76
Antagonists of glutamate in the treatment of Parkinson's disease: from laboratory to the clinic. Amino Acids (1998) 0.76
Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors. Eur J Pharmacol (1995) 0.76
Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice. Psychopharmacology (Berl) (1994) 0.76
Potentiation by substance P of contractions of the isolated vas deferens of the mouse elicited by electric field stimulation and by drugs. Br J Pharmacol (1978) 0.75
Effect of amino-oxyacetic acid on the accumulation of 3H- -aminobutyric acid (3H-GABA) by rat retina. Br J Pharmacol (1973) 0.75
The importance of plasma kinins in the anaphylactoid reaction in rats. Br J Pharmacol Chemother (1967) 0.75
Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysis. Brain Res (1995) 0.75
D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice. Neuroreport (1993) 0.75
Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience (1994) 0.75
Further evidence for the involvement of kinin in anaphylactic shock in the rat. Br J Pharmacol (1969) 0.75
Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol Biochem Behav (1990) 0.75
Effect of light stimulation on the synthesis and release of GABA in rat and frog retinae. Brain Res (1975) 0.75
Effects of metabolic inhibitors on amino acid metabolism in rat retina: a comparison of amino-oxyacetic acid and ethanolamine-o-sulphate. J Neurochem (1975) 0.75
A comparative study of the utilization of glucose, acetate, glutamine and GABA as precursors of amino acids by retinal of the rat, frog, rabbit and pigeon. Biochem Pharmacol (1975) 0.75
Circling evoked by intranigral SKF 38393: a GABA-mediated D-1 response? Pharmacol Biochem Behav (1989) 0.75
Effects of changes in the ionic composition of the incubation medium on the accumulation and metabolism of 3 H- -aminobutyric acid and 14 C-taurine in isolated rat retina. Biochem Pharmacol (1973) 0.75